Program – 4 August 2022
02:00 pm British Summer Time
02:00 pm British Summer Time
02:00 – 02:05 pm
Welcome & Introductions
02:05 – 2:30 pm
Pharmacological interventions for managing behaviours of people with autism spectrum disorder (ASD) – a systematic review of effectiveness and adverse effects
Donna Gillies, PhD, Director, Research and Practice Evidence at NDIS Quality and Safeguards Commission
02:30 – 02:35 pm
Questions
02:35 – 03:15 pm
The Integrated Mental Health Treatment Guidelines for Prescribers in Intellectual and Developmental Disabilities
Jennifer McLaren, M.D., Chief Medical Advisor, National Center for START Services, Associate Professor of Psychiatry, Pediatrics and The Dartmouth Institute, Geisel School of Medicine at Dartmouth, Dartmouth Health
Andrea Caoili, LCSW, MSW, Director of Research and Quality Assurance, National Center for START Services, Institute on Disability/UCED, University of New Hampshire
Joan Beasley, PhD, MEd, Research Professor, Director, National Research Consortium on IDD-MH, National Center for START Services, Institute on Disability/UCED, University of New Hampshire
03:15 – 03.30 pm
Questions to the panel
The International Association for the Scientific Study of Intellectual and Developmental Disabilities (IASSIDD) is the first and only world-wide group dedicated to the scientific study of intellectual disability.
Founded in 1964 as the International Association for the Scientific Study of Mental Deficiency, IASSIDD is an international, interdisciplinary and scientific non-governmental organization which promotes worldwide research and exchange of information on intellectual disabilities.
This site uses cookies. Find out more about cookies and how you can refuse them.